Procedure/assessment | Screen 1 | Screen 2 | Baseline (0 months) | Intervention period | FU1 (3 months) | Interval b/w FUs | FU2 (6 months) |
---|---|---|---|---|---|---|---|
Enrolment: | Â | Â | Â | Â | Â | Â | Â |
 Initial eligibility screen | X |  |  |  |  |  |  |
 Informed consent | X |  |  |  |  |  |  |
 Demographic information | X |  |  |  |  |  |  |
 Randomisation |  |  | X |  |  |  |  |
Interventions: | Â | Â | Â | Â | Â | Â | Â |
 SMART + TAU |  |  |  | X |  |  |  |
 Active control training + TAU |  |  |  | X |  |  |  |
 TAU |  |  |  | X |  |  |  |
Assessments: | Â | Â | Â | Â | Â | Â | Â |
 PDQ | X |  |  |  | X |  | X |
 Symbol Digit Modalities Test (SDMT) |  | X |  |  | X |  | X |
 RBANS |  |  | X |  | X |  | X |
 Generalized Anxiety Disorder Scale-7 (GAD-7) |  |  |  |  |  |  |  |
 Patient Health Questionnaire-9 (PHQ-9) |  |  | X |  | X |  | X |
 Modified Fatigue Impact Scale–5-Item (MFIS-5) |  |  | X |  | X |  | X |
 Personal Questionnaire (PQ) |  |  | X |  | X |  | X |
 EQ-5D-5L |  |  | X |  | X |  | X |
 MS Impact Scale–29 (MSIS-8D; v.2) |  |  | X |  | X |  | X |
 ICECAP-A |  |  | X |  | X |  | X |
 Service- and resource-use questionnaire |  |  | X |  | X |  | X |
 Feedback interviews |  |  |  |  |  | Xa |  |